MSR1 and early-onset autosomal dominant Alzheimer disease: MSR1 has been shown to have activity in macrophage polarisation, pro-inflammatory signalling, pathogen clearance, Alzheimer’s disease, atherosclerosis, non-alcoholic fatty liver disease, and cancer (Gudgeon et al, 2022).